Filing Details
- Accession Number:
- 0001179110-17-001952
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-08 16:24:27
- Reporting Period:
- 2017-02-06
- Filing Date:
- 2017-02-08
- Accepted Time:
- 2017-02-08 16:24:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1399519 | M David Weber | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2017-02-06 | 21,250 | $5.86 | 123,771 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2017-02-06 | 500 | $105.37 | 123,271 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2017-02-06 | 3,200 | $106.89 | 120,071 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2017-02-06 | 6,130 | $107.72 | 113,941 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2017-02-06 | 6,361 | $108.66 | 107,580 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2017-02-06 | 5,059 | $109.78 | 102,521 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-02-06 | 14,000 | $0.00 | 14,000 | $5.86 |
| Common Stock | Stock Options (right to buy) | Disposition | 2017-02-06 | 7,250 | $0.00 | 7,250 | $5.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-05-28 | 2019-05-28 | No | 4 | M | Direct |
| 21,250 | 2010-03-31 | 2019-05-28 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 50,000 | Direct |
| Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 25,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 23,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 15,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 10,000 | Direct |
| Common Stock | Stock Option (right to buy) | $99.62 | 2017-05-24 | 2026-05-24 | 0 | 7,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-06-03 | 0 | 50,000 | Direct |
| 2022-05-22 | 0 | 25,000 | Direct |
| 2023-05-14 | 0 | 23,000 | Direct |
| 2024-05-14 | 0 | 15,000 | Direct |
| 2025-05-13 | 0 | 10,000 | Direct |
| 2026-05-24 | 0 | 7,000 | Direct |
Footnotes
- This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $105.1100 and $105.7900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $106.2300 and $107.1700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $107.2500 and $108.2400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $108.2600 and $109.2100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $109.3300 and $110.1600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
